Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh